RESUMO
AIM: The final common pathway in the etiopathogenesis of schizophrenia is suggested that there is a defect in the presynaptic terminal in dopaminergic transmission, in which α-synuclein has an important role. Peripheral biomarker studies in schizophrenia have become crucial for better diagnoses, early interventions, and personalized therapies. This study aims to compare α-synuclein levels in patients with schizophrenia and their unaffected siblings with healthy controls, as a potential peripheral biomarker for schizophrenia. METHODS: The quantifications of α-synuclein serum concentrations were conducted by the ELISA method. PANSS and CGI-S were used to analyse the severity of the symptoms of the subjects. Data were analysed by nonparametric tests and the Receiver Operating Curve (ROC) analysis. RESULTS: Sixty-two patients with schizophrenia (mean age: 34,8 ± 9,9, %64,5 male), their 56 unaffected siblings (mean age: 39,4 ± 11,5, %55,4 male) and 56 healthy controls (mean age: 36,2 ± 9,8, %64,3 male) were included. α-synuclein levels were significantly lower in the patient (27,65 (12,61-46,09) pg/ml) and the unaffected sibling groups (24,62 (15,60-57,87) pg/ml) compared with healthy controls (45,58 (11,25-108,30) pg/ml) (p < .001). According to the ROC analysis, the optimal cut-off value for α-synuclein levels in distinguishing the schizophrenia group from the control group was 42.20. The sensitivity of the measurement of serum α-synuclein at this point was 93.5%, and the specificity was 60.7%. CONCLUSION: Our study demonstrates that decreased levels of serum α-synuclein may be utilized as a possible peripheral biomarker of familial risk for schizophrenia in both patients and their siblings.
Assuntos
Esquizofrenia , Humanos , Masculino , alfa-Sinucleína , Biomarcadores , Nível de Saúde , Esquizofrenia/diagnóstico , Irmãos , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-IdadeRESUMO
PURPOSE: Aminoacylase 1 (ACY1) catalyzes the hydrolysis reaction during protein degradation. N-acetylamino acids are accumulated in the urine in Aminoacylase 1 deficiency (ACY1D). This study attempts to evaluate the potential of ACY1 as a biomarker for schizophrenia and predict genetic vulnerability in the high-risk population. MATERIAL AND METHODS: Seventy patients with schizophrenia, twenty-five of which have newly diagnosed, forty-nine unaffected siblings of patients, and fifty-six healthy controls were included in the study. The ELISA method was used to measure serum ACY1. The Positive and Negative Syndrome Scale (PANSS) and The Clinical Global Impression - Severity scale (CGI-S) were used to analyze the severity of the symptoms. Data were analysed statistically by non-parametric tests. RESULTS: The finding of the study indicated that the serum levels of ACY1 in patients and siblings were lower compared to healthy controls (p < 0.001 and p = 0.023). There was no statistically significant difference between patients and siblings (p = 0.067). The duration of disease, PANSS total scores, and CGI-S scores did not have a significant association with the ACY1 levels in the patient group (p > 0.005). ACY1 levels among the drug-using patient group and the newly diagnosed patient group showed no notable difference (respectively, p = 0.120 and p = 0.843). CONCLUSION: This study is the first to evaluate the serum ACY1 levels in patients with schizophrenia. The result of the study provides us insight regarding the first hints that ACY1 might be a potential biomarker. Being aware of the molecule will pave the way for further explorations in the field.
Assuntos
Esquizofrenia , Amidoidrolases/genética , Amidoidrolases/metabolismo , Biomarcadores , Humanos , Esquizofrenia/diagnóstico , IrmãosRESUMO
BACKGROUND: Neuronal pentraxin-2 (NPTX2, an immediate-early gene), which regulates synapse activity and neuroplasticity, plays an essential role in the neurodevelopmental process. NPTX2 possibly enhances the accumulation of amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptors (AMPAR) on the postsynaptic membranes and stimulates excitatory synaptogenesis. We aimed to evaluate the plasma concentrations of NPTX2 of patients with schizophrenia in acute psychotic episodes compared with matched community-based controls. METHODS: Ninety-three (93) patients diagnosed with schizophrenia according to DSM-5 and 83 healthy controls were included. The patients, all of which were in acute psychotic episodes, were recruited from the inpatient clinic. The patients were assessed by the Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression- Severity (CGIS) scale, whereas the healthy subjects were evaluated with Structured Clinical Interview for DSM-5 (SCID-5) to exclude any major psychiatric diagnoses. RESULTS: NPTX2 serum concentrations were significantly higher in the schizophrenia group (p < 0.001). NPTX2 levels negatively correlated with age (p = 0.004) and PANSS-positive symptom scores (p < 0.001). The most determinant factors in predicting the change in NPTX2 levels were PANSS-positive symptom and general psychopathology scores. CONCLUSIONS: We conclude that NPTX2 could be involved in schizophrenia pathophysiology and valuable as a synapse-derived and glutamate-related biomarker. Further studies in larger samples assessing NPTX2 levels in remitted schizophrenia patients and combining neuroimaging techniques and cognitive evaluations with blood samples are needed.
Assuntos
Transtornos Psicóticos , Esquizofrenia , Proteína C-Reativa , Humanos , Proteínas do Tecido Nervoso/genética , Transtornos Psicóticos/diagnósticoRESUMO
OBJECTIVE: In this study we aimed to investigate the frequency and the factors determining the conversion rate of the oral and poster presentations into articles. Five consecutive national psychiatry congresses held by the Psychiatric Association of Turkey (PAT) between 2012 and 2016 were evaluated. METHOD: The manuscripts published in peer-reviewed journals were identified using the Web of Knowledge, PubMed and Google Scholar databases. The identified manuscripts were classified according to the type of the publication, the duration until publication, the impact factor and the index of the journal. RESULTS: Out of the total 1372 reports presented at the five consecutive National Congress of Psychiatry events, a total of 297 abstracts (21.6%), comprising 201 of the 1104 posters and 96 of the 268 oral presentations, were converted in to publications. A significantly higher percentage of the oral presentations (p<0.001) compared to the poster presentations were converted into publications; and more of the publications consisted of research reports as compared to case reports. The mean time taken from presentation at the congress to publication was 19.04 (±12.47) months. The mean impact factor of the journals at the time of publication was 1.45 (±1.49). CONCLUSION: Although the publication percentage of the presentations made in National Congress of Psychiatry events held by the PAT is similar to that of other studies conducted in Turkey, they are below the percentage reported by similar research in the international literature. There is a need in the mental healthcare institutions of Turkey for time allocation to make research and for creating units that can support researchers in the difficult process of publishing research results. Also, a more selective approach should be adopted when evaluating the congress presentations, and research that is considered to be of high academic value should be encouraged for submission as oral presentations.